                         SEQUENCE LISTING

<110>  BIOHAVEN THERAPEUTICS LTD
 
<120>  COMPOSITIONS INCLUDING CONJUGATED THERAPY ENHANCERS

<130>  BHL0031US

<150>  63/189,503
<151>  2021-05-17

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  di-sulfid
<222>  (2)..(12)

<400>  1

Asp Cys Ala Trp Xaa Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  2
<211>  56
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic

<400>  2

Asp Lys Glu Trp Ile Leu Gln Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly His Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Tyr Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  3
<211>  64
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3

Asn Asp Asp Glu Leu His Met Leu Met Thr Asp Leu Val Tyr Glu Ala 
1               5                   10                  15      


Leu His Phe Ala Lys Asp Glu Glu Ile Lys Lys Arg Val Phe Gln Leu 
            20                  25                  30          


Phe Glu Leu Ala Asp Lys Ala Tyr Lys Asn Asn Asp Arg Gln Lys Leu 
        35                  40                  45              


Glu Lys Val Val Glu Glu Leu Lys Glu Leu Leu Glu Arg Leu Leu Ser 
    50                  55                  60                  


